Cargando…

The Preventive Value of Acupoint Sensitization for Patients with Stable Angina Pectoris: A Randomized, Double-Blind, Positive-Controlled, Multicentre Trial

BACKGROUND: Acupoint sensitization is considered an important factor in the efficacy of acupoint therapy. This study aimed to evaluate the efficacy of acupressure in the prevention of stable angina pectoris using acupoints with different pressure-pain sensitivities. METHODS: A total of 202 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Shourui, Li, Ling, Liu, Jiali, Li, Xiujuan, Shi, Qingyang, Li, Ying, Liu, Yanping, Li, Mingxiu, Ma, Li, Ning, Liang, Liao, Xiaoyang, Ying, Xihui, Cai, Weiye, Yang, Fuyu, Wang, Tengfei, Guo, Ru, Ma, Weijie, Chen, Wenzhu, Chen, Jin, Sun, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577890/
https://www.ncbi.nlm.nih.gov/pubmed/34765004
http://dx.doi.org/10.1155/2021/7228033
_version_ 1784596155217215488
author Huang, Shourui
Li, Ling
Liu, Jiali
Li, Xiujuan
Shi, Qingyang
Li, Ying
Liu, Yanping
Li, Mingxiu
Ma, Li
Ning, Liang
Liao, Xiaoyang
Ying, Xihui
Cai, Weiye
Yang, Fuyu
Wang, Tengfei
Guo, Ru
Ma, Weijie
Chen, Wenzhu
Chen, Jin
Sun, Xin
author_facet Huang, Shourui
Li, Ling
Liu, Jiali
Li, Xiujuan
Shi, Qingyang
Li, Ying
Liu, Yanping
Li, Mingxiu
Ma, Li
Ning, Liang
Liao, Xiaoyang
Ying, Xihui
Cai, Weiye
Yang, Fuyu
Wang, Tengfei
Guo, Ru
Ma, Weijie
Chen, Wenzhu
Chen, Jin
Sun, Xin
author_sort Huang, Shourui
collection PubMed
description BACKGROUND: Acupoint sensitization is considered an important factor in the efficacy of acupoint therapy. This study aimed to evaluate the efficacy of acupressure in the prevention of stable angina pectoris using acupoints with different pressure-pain sensitivities. METHODS: A total of 202 patients were enrolled and randomly assigned to a high-sensitivity group (HSG) (n = 109) in which patients received acupressure at the five acupoints with the highest sensitivity to pain and a low-sensitivity group (LSG) (n = 93) in which patients received acupressure at the five acupoints with the lowest sensitivity to pain. The duration of acupressure treatment was 4 weeks, and the patients were evaluated at baseline, week 4, and week 8. The primary outcome was a change in the frequency of angina attacks from baseline. The secondary outcomes included nitroglycerin consumption, the Canadian Cardiovascular Society classification, and the Seattle Angina Questionnaire score. Adverse events such as bleeding and subcutaneous haemorrhage were recorded in both groups. RESULTS: The effect of acupressure compared with baseline on the prevention of angina pectoris in HSG was better than that in LSG at week 4 (incidence rate ratio (IRR): 0.691 and 95% confidence interval (CI): [0.569, 0.839]) and week 8 (IRR: 0.692 and 95% CI: [0.569, 0.839]). No significant difference between groups was found in the frequency of nitroglycerin consumption at week 4 (odds ratio (OR) = 0.863 and 95% CI: [0.147, 5.077]) or week 8 (OR = 1.426 and 95% CI: [0.211, 9.661]). Two themes in the questionnaire showed significantly different changes from baseline between the two groups. Scores on the angina frequency (AF) subscale had changed more from the baseline in the HSG at week 8 than in the LSG (mean difference (MD) = 3.807 and 95% CI: [0.673, 6.942]). Scores on the treatment satisfaction (TS) subscale had also changed more in the HSG than in the LSG at week 4 (MD = 3.651 and 95% CI: [0.327, 7.327]) and week 8 (MD = 4.220 and 95% CI: [0.347, 7.346]). One patient in the LSG reported bruising at the acupoint. No unexpected safety problems arose. CONCLUSIONS: This study showed that acupressure at acupoints with high sensitivity to pain may effectively reduce the frequency of stable angina pectoris episodes. This trial is registered with NCT03975140.
format Online
Article
Text
id pubmed-8577890
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-85778902021-11-10 The Preventive Value of Acupoint Sensitization for Patients with Stable Angina Pectoris: A Randomized, Double-Blind, Positive-Controlled, Multicentre Trial Huang, Shourui Li, Ling Liu, Jiali Li, Xiujuan Shi, Qingyang Li, Ying Liu, Yanping Li, Mingxiu Ma, Li Ning, Liang Liao, Xiaoyang Ying, Xihui Cai, Weiye Yang, Fuyu Wang, Tengfei Guo, Ru Ma, Weijie Chen, Wenzhu Chen, Jin Sun, Xin Evid Based Complement Alternat Med Research Article BACKGROUND: Acupoint sensitization is considered an important factor in the efficacy of acupoint therapy. This study aimed to evaluate the efficacy of acupressure in the prevention of stable angina pectoris using acupoints with different pressure-pain sensitivities. METHODS: A total of 202 patients were enrolled and randomly assigned to a high-sensitivity group (HSG) (n = 109) in which patients received acupressure at the five acupoints with the highest sensitivity to pain and a low-sensitivity group (LSG) (n = 93) in which patients received acupressure at the five acupoints with the lowest sensitivity to pain. The duration of acupressure treatment was 4 weeks, and the patients were evaluated at baseline, week 4, and week 8. The primary outcome was a change in the frequency of angina attacks from baseline. The secondary outcomes included nitroglycerin consumption, the Canadian Cardiovascular Society classification, and the Seattle Angina Questionnaire score. Adverse events such as bleeding and subcutaneous haemorrhage were recorded in both groups. RESULTS: The effect of acupressure compared with baseline on the prevention of angina pectoris in HSG was better than that in LSG at week 4 (incidence rate ratio (IRR): 0.691 and 95% confidence interval (CI): [0.569, 0.839]) and week 8 (IRR: 0.692 and 95% CI: [0.569, 0.839]). No significant difference between groups was found in the frequency of nitroglycerin consumption at week 4 (odds ratio (OR) = 0.863 and 95% CI: [0.147, 5.077]) or week 8 (OR = 1.426 and 95% CI: [0.211, 9.661]). Two themes in the questionnaire showed significantly different changes from baseline between the two groups. Scores on the angina frequency (AF) subscale had changed more from the baseline in the HSG at week 8 than in the LSG (mean difference (MD) = 3.807 and 95% CI: [0.673, 6.942]). Scores on the treatment satisfaction (TS) subscale had also changed more in the HSG than in the LSG at week 4 (MD = 3.651 and 95% CI: [0.327, 7.327]) and week 8 (MD = 4.220 and 95% CI: [0.347, 7.346]). One patient in the LSG reported bruising at the acupoint. No unexpected safety problems arose. CONCLUSIONS: This study showed that acupressure at acupoints with high sensitivity to pain may effectively reduce the frequency of stable angina pectoris episodes. This trial is registered with NCT03975140. Hindawi 2021-11-02 /pmc/articles/PMC8577890/ /pubmed/34765004 http://dx.doi.org/10.1155/2021/7228033 Text en Copyright © 2021 Shourui Huang et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Huang, Shourui
Li, Ling
Liu, Jiali
Li, Xiujuan
Shi, Qingyang
Li, Ying
Liu, Yanping
Li, Mingxiu
Ma, Li
Ning, Liang
Liao, Xiaoyang
Ying, Xihui
Cai, Weiye
Yang, Fuyu
Wang, Tengfei
Guo, Ru
Ma, Weijie
Chen, Wenzhu
Chen, Jin
Sun, Xin
The Preventive Value of Acupoint Sensitization for Patients with Stable Angina Pectoris: A Randomized, Double-Blind, Positive-Controlled, Multicentre Trial
title The Preventive Value of Acupoint Sensitization for Patients with Stable Angina Pectoris: A Randomized, Double-Blind, Positive-Controlled, Multicentre Trial
title_full The Preventive Value of Acupoint Sensitization for Patients with Stable Angina Pectoris: A Randomized, Double-Blind, Positive-Controlled, Multicentre Trial
title_fullStr The Preventive Value of Acupoint Sensitization for Patients with Stable Angina Pectoris: A Randomized, Double-Blind, Positive-Controlled, Multicentre Trial
title_full_unstemmed The Preventive Value of Acupoint Sensitization for Patients with Stable Angina Pectoris: A Randomized, Double-Blind, Positive-Controlled, Multicentre Trial
title_short The Preventive Value of Acupoint Sensitization for Patients with Stable Angina Pectoris: A Randomized, Double-Blind, Positive-Controlled, Multicentre Trial
title_sort preventive value of acupoint sensitization for patients with stable angina pectoris: a randomized, double-blind, positive-controlled, multicentre trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577890/
https://www.ncbi.nlm.nih.gov/pubmed/34765004
http://dx.doi.org/10.1155/2021/7228033
work_keys_str_mv AT huangshourui thepreventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial
AT liling thepreventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial
AT liujiali thepreventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial
AT lixiujuan thepreventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial
AT shiqingyang thepreventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial
AT liying thepreventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial
AT liuyanping thepreventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial
AT limingxiu thepreventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial
AT mali thepreventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial
AT ningliang thepreventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial
AT liaoxiaoyang thepreventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial
AT yingxihui thepreventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial
AT caiweiye thepreventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial
AT yangfuyu thepreventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial
AT wangtengfei thepreventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial
AT guoru thepreventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial
AT maweijie thepreventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial
AT chenwenzhu thepreventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial
AT chenjin thepreventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial
AT sunxin thepreventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial
AT huangshourui preventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial
AT liling preventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial
AT liujiali preventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial
AT lixiujuan preventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial
AT shiqingyang preventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial
AT liying preventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial
AT liuyanping preventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial
AT limingxiu preventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial
AT mali preventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial
AT ningliang preventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial
AT liaoxiaoyang preventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial
AT yingxihui preventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial
AT caiweiye preventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial
AT yangfuyu preventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial
AT wangtengfei preventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial
AT guoru preventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial
AT maweijie preventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial
AT chenwenzhu preventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial
AT chenjin preventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial
AT sunxin preventivevalueofacupointsensitizationforpatientswithstableanginapectorisarandomizeddoubleblindpositivecontrolledmulticentretrial